Parkman Healthcare Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.6M	Buy	280,575 +135,575	+94%	+$10.6M	2.24%	14
2025 Q4	$11.4M	Buy	+145,000	New	+$12.6M	1.09%	35
2025 Q3	–	Sell	-128,478	Closed	-$8.38M	–	94
2025 Q2	$8.38M	Buy	128,478 +23,478	+22%	+$1.53M	0.97%	36
2025 Q1	$7.03M	Buy	+105,000	New	+$6.27M	0.83%	42
2023 Q4	–	Sell	-111,802	Closed	-$6.49M	–	93
2023 Q3	$6.49M	Sell	111,802 -62,675	-36%	-$3.62M	1.19%	29
2023 Q2	$9.39M	Buy	174,477 +74,477	+74%	+$3.3M	1.63%	21
2023 Q1	$3.97M	Sell	100,000 -26,874	-21%	-$1.13M	0.86%	41
2022 Q4	$5.1M	Buy	126,874 +8,933	+8%	+$336K	1.36%	26
2022 Q3	$3.79M	Buy	117,941 +9,382	+9%	+$321K	1.08%	31
2022 Q2	$3.22M	Buy	108,559 +648	+0.6%	+$18.7K	1.19%	27
2022 Q1	$3.03M	Sell	107,911 -29,315	-21%	-$1.09M	0.89%	39
2021 Q4	$6.32M	Buy	137,226 +51,880	+61%	+$2.23M	1.43%	27
2021 Q3	$2.8M	Buy	85,346 +30,000	+54%	+$933K	0.71%	44
2021 Q2	$1.94M	Buy	+55,346	New	+$1.88M	0.42%	60